SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

ZUCCATO, Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.330
EU - Europa 1.967
AS - Asia 1.194
OC - Oceania 12
AF - Africa 11
SA - Sud America 11
Totale 7.525
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.317
CN - Cina 707
PL - Polonia 567
IT - Italia 383
UA - Ucraina 313
DE - Germania 253
TR - Turchia 178
GB - Regno Unito 135
SG - Singapore 135
SE - Svezia 100
FI - Finlandia 76
FR - Francia 51
ID - Indonesia 45
IN - India 25
NL - Olanda 18
CZ - Repubblica Ceca 15
HK - Hong Kong 14
IR - Iran 14
VN - Vietnam 14
PK - Pakistan 13
BE - Belgio 12
GR - Grecia 12
AU - Australia 11
MY - Malesia 9
RU - Federazione Russa 9
CA - Canada 8
JP - Giappone 7
KR - Corea 7
BR - Brasile 6
CH - Svizzera 5
MX - Messico 5
RO - Romania 5
TH - Thailandia 5
TN - Tunisia 5
AT - Austria 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
EG - Egitto 3
IL - Israele 3
EC - Ecuador 2
IE - Irlanda 2
KZ - Kazakistan 2
PH - Filippine 2
ZA - Sudafrica 2
BD - Bangladesh 1
BG - Bulgaria 1
CY - Cipro 1
EE - Estonia 1
ES - Italia 1
KW - Kuwait 1
LI - Liechtenstein 1
LY - Libia 1
MT - Malta 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RS - Serbia 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
UZ - Uzbekistan 1
Totale 7.525
Salva come PNG Salva come JPEG
Città #
Woodbridge 573
Warsaw 566
Chandler 411
Fairfield 407
Jacksonville 381
Houston 298
Ashburn 297
Ann Arbor 296
Beijing 225
Wilmington 181
Seattle 135
Nanjing 134
Ferrara 122
Cambridge 120
Izmir 114
Princeton 91
Singapore 75
Boardman 65
Bologna 65
New York 64
Addison 61
Shanghai 59
Bremen 55
Milan 45
Redwood City 41
Shenyang 40
San Diego 38
Jakarta 34
Los Angeles 31
Nanchang 25
Jiaxing 24
Dearborn 22
Jinan 22
Hebei 20
Auburn Hills 19
Changsha 19
Ferrara di Monte Baldo 17
Tianjin 17
Falls Church 15
Dong Ket 14
Hong Kong 14
Mountain View 14
Leiden 13
Brno 12
Munich 12
Zhengzhou 12
Brussels 11
Guangzhou 11
Hefei 11
Norwalk 11
San Jose 11
Ningbo 9
Verona 9
Fars 8
Indiana 8
Kunming 8
Des Moines 7
London 7
Orange 7
Leawood 6
Yogyakarta 6
Cattolica 5
Chengdu 5
Hangzhou 5
San Mateo 5
Sydney 5
Washington 5
Bournemouth 4
Changchun 4
Fuzhou 4
Hyderabad 4
Kota Bharu 4
Lanzhou 4
Lappeenranta 4
Napoli 4
Philadelphia 4
Ravenna 4
Somerville 4
Southwark 4
Taipei 4
Thessaloníki 4
Toronto 4
Bagnolo San Vito 3
Bangalore 3
Buenos Aires 3
Colchester 3
Kuala Lumpur 3
Kundan 3
Leeds 3
New Delhi 3
Tappahannock 3
Waban 3
Abu Dhabi 2
Amsterdam 2
Aversa 2
Bern 2
Brampton 2
Camisano Vicentino 2
Campobasso 2
Castel Maggiore 2
Totale 5.581
Salva come PNG Salva come JPEG
Nome #
An Aγ-globin G->A gene polymorphism associated with β(0)39 thalassemia globin gene and high fetal hemoglobin production 301
A validated cellular biobank for β-thalassemia 267
TREATMENT OF BETA-THALASSEMIA PATIENTS WITH RAPAMYCIN (SIROLIMUS): FROM PRE-CLINICAL RESERCH TO A CLINICAL TRIAL 247
BCL11A mRNA targeting by miR-210: A possible network regulating γ-globin gene expression 222
A validated THALAMOSS cellular biobank for β-thalassemia 187
The (A)gamma(+25 G -> A) polymorphism is associated with high HbF production leading to a decrease in binding activity of the LYAR transcription factor to the (A)gamma-globin gene in beta-thalassemia patients 167
Generation and characterization of a transgenic mouse carrying a functional human β-globin gene with the IVSI-6 thalassemia mutation 164
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 144
A Novel Frameshift Mutation (+A) at Codon 18 of the beta-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and deltabeta-Thalassemia 132
Structure and Biological Activity of Furocoumarins 122
Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: Induction of production of fetal hemoglobin in human erythroid precursor cells 118
Combining gene therapy and fetal hemoglobin induction for treatment of β-thalassemia. 115
Effects on erythroid differentiation of platinum(II) complexes of synthetic bile acid derivatives 113
A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction 111
Generation and molecular characterization of a transgenic mouse line carrying a mutated human IVS-I-6 thalassemia beta-globin gene 109
null 107
Differentiation and apoptosis in UVA-irradiated cells treated with furocoumarin derivatives 107
Induction of erythroid differentiation and increased globin mRNA production with furocoumarins and their photoproducts 104
null 103
PNAs targeting BCL11A at the miR-210 binding sites down-regulate BCL11A and up-regulate gamma-globin mRNA 103
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β(0)-Thalassemia Families with High Fetal Hemoglobin Levels 101
Erythroid Induction of Chronic Myelogenous Leukemia K562 Cells Following Treatment with a Photoproduct Derived from the UV-A Irradiation of 5-Methoxypsoralen 99
Involvement of miRNA in erythroid differentiation 99
Erythroid differentiation ability of butyric acid analogues: Identification of basal chemical structures of new inducers of foetal haemoglobin 99
The multicenter THALAMOSS cellular Biobank for β-Thalassemia 99
Preparation and biological evaluation of some 1,2-O-isopropylidene-D-hexofuranose esters 98
Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients. 98
Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G>A) polymorphic Aγ-globin gene sequences mutated in β-thalassemia 96
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters 95
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassemia mutation for the screening of correctors of stop codon mutations 93
Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients 90
Synthesis and cellular pharmacology studies of a series of 2-amino-3-aroyl-4-substituted thiophene derivatives 90
A Saccharomyces cerevisiae model suitable for screening of correctors of stop-codon mutations 89
Induction of erythroid differentiation and increased globin mRNA production with furocoumarins and their photoproducts. 88
null 87
null 85
Recent trends in the gene therapy of β-thalassemia 85
Production and molecular characterization of transgenic mice models for screening therapeutic agents for beta-thalassemia 84
Encapsulation of mithramycin into polymeric micelles by microfluidics: Regulation of the expression of the human γ-globin genes 84
Discovery of novel fetal hemoglobin inducers for β-thalassemia by small chemical library screening 84
Double effects of mithramycin during induction of fetal hemoglobin: down regulation of BCL11A gene transcription and inhibition of the binding of the BCL11A transcriptional complex to the -globin gene promoter 81
Combining gene therapy with fetal hemoglobin induction on erythroid precursor cells from β039 and IVS-I-110 thalassemia patients 81
Gene therapy combined with HbF induction in beta-thalassemia 80
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of gamma-globin and beta-globin gene promoters 79
Development and molecular characterization of transgenic mice for beta-thalassemia 76
Everolimus is a potent inducer of erythroid differentation and gamma-globin gene expression in human erythroid cells 75
Increase of the expression of gamma-globin gene in human erytroid cells treated with psoralens 75
null 75
Effects of rapamycin on accumulation of alpha-, beta- and gamma-globin mRNAs in erythroid precursor cells from beta-thalassaemia patients 72
Transcription factors (TFs) negatively regulating gamma-globin gene transcription: BCL11A is down-regulated during mithramycin induction of erythroid cells from beta-thalassemia patients 72
Effects of Tobramycin activity on premature termination codons and interleukin 8 gene expression 70
Production of s-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous s039 thalassemia patients 69
Targeting the miR-221/miR-222 cluster in cancer therapy 68
Mithramycin-mediated regulation of raptor gene transcription during erythroid differentiation of K562 cells 66
Gene therapy and fetal hemoglobin induction 65
Thalassemia mouse model for beta-globin gene IVSI-6 mutation 65
Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs 62
Cellular biosensors for the identification of fetal hemoglobin inducers 61
Bergamot (Citrus bergamia Risso) fruit extracts as gamma-globin gene expression inducers: Phyto-chemical and functional perspectives 61
Mithramycin-mediated induction of K562 cell erythroid differentiation is associated with inhibition of the mTOR-CI patway 60
Generation and molecular characterization of a transgenic mouse line carrying a mutated human °39 thalassemia -globin gene 59
Increase of accumulationof gamma-globin mRNA in human erythroid cells treated with psoralens 58
Readthrough of the premature stop codon beta039-thalassemia 58
Production of a cellular model for the screening of inducers of fetal haemoglobin 57
Therapeutic molecules for the development of a read-through approach for diseases caused by nonsense mutations 56
New synthetic isoxazole derivatives as potent inducer of fetal hemoglobin (HbF) in beta-thalassemia 56
null 52
Erythroid differentiation induced by mithramycin in K562 cells is associated with inhibition of the mTOR-C1 pathway 52
Sirolimus-mediated induction of fetal hemoglobin in beta-thalassemia: impact of the XmnI rs74482144 polymophism 51
Human bladder carcinoma cell line 5637 encapsulated in alginate microbeads: release of interleukins, chemokines and growth factors. 50
Hemoglobin production in beta-thalassemia erythroid cells following alteration of biomolecular pathways regulating globin gene expression 49
Down-regulation of LYAR is associated with induction of fetal hemoglobin in mithramycin-treated erythroid cells 49
null 48
Expression of miR-210 during erythroid differentiation and induction of gamma-globin gene expression 46
Induction of accumulation of gamma-globin mRNA in human erythroid cells treated with psoralens 44
null 44
Induction of accumulation of gamma-globin mRNA in human erythroid cells treated with psoralens 43
Sex-specific transcriptional profiles identified in β-thalassemia patients 43
null 40
Novel biological activity of psoralens. Induction of accumulation of g-globin mRNA in human erythroid cells 39
Efficient CRISPR-Cas9-based genome editing of β-globin gene on erythroid cells from homozygous β039-thalassemia patients 36
Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin) 35
null 32
Ultra sensitive plasmonic devices for early cancer diagnosis 30
A Rational Approach to Drug Repositioning in β-thalassemia: Induction of Fetal Hemoglobin by Established Drugs 29
Treatment of erythroid precursor cells from β‐thalassemia patients with cinchona alkaloids: Induction of fetal hemoglobin production 27
Teaching during COVID-19 pandemic in practical laboratory classes of applied biochemistry and pharmacology: A validated fast and simple protocol for detection of SARS-CoV-2 Spike sequences 23
THALAssaemia MOdular Stratification System for personalized therapy of beta-thalassemia 23
Effects of Sirolimus treatment on patients with β-Thalassemia: Lymphocyte immunophenotype and biological activity of memory CD4+ and CD8+ T cells 22
Co-Treatment of Erythroid Cells from β-Thalassemia Patients with CRISPR-Cas9-Based β039-Globin Gene Editing and Induction of Fetal Hemoglobin 21
Evidences for miRNA regulation of BCL11A gene expression 21
Furocoumarins photolysis products induce differentiation of human erythroid cells 19
Orphan Drugs and Potential Novel Approaches for Therapies of β-Thalassemia: Current Status and Future Expectations 18
Development of a transgenic mouse line carrying a functional human Beta-globin gene with the IVSI-6 thalassemia mutation for in vivo screening and validation of aberrant splicing correctors 17
The rs368698783 (G>A) Polymorphism Affecting LYAR Binding to the Aγ-Globin Gene Is Associated with High Fetal Hemoglobin (HbF) in β-Thalassemia Erythroid Precursor Cells Treated with HbF Inducers 17
Expression of miR-210 during erythroid differentiation and induction of gamma-globin gene expression 14
Decrease in α-Globin and Increase in the Autophagy-Activating Kinase ULK1 mRNA in Erythroid Precursors from β-Thalassemia Patients Treated with Sirolimus 11
Tobramycin is a suppressor of premature termination codons. 11
Fetal Hemoglobin Inducers from the Natural World: 5 A Novel Approach for Identification of Drugs for the Treatment of b-Thalassemia and Sickle-Cell Anemia 10
Mithramycin-mediated regulation of raptor gene transcription during erythroid differentiation of K562 cells 10
Totale 7.719
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.544
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 351
Totale 32.895
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.204 0 46 51 175 93 174 100 128 119 200 76 42
2020/20211.248 98 64 65 92 89 126 58 135 35 155 213 118
2021/2022852 87 77 37 25 50 42 46 37 23 80 85 263
2022/2023958 95 91 23 125 174 129 72 82 81 8 42 36
2023/2024673 34 103 27 17 82 124 78 45 10 8 16 129
2024/2025127 74 53 0 0 0 0 0 0 0 0 0 0
Totale 7.768